Ledger.Open graph →
SEC Form D · filed October 27, 2016

Gemstone BioTherapeutics, LLC

Offering
$3.5M
Sold
$700K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BALTIMORE, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

David Oros · Baltimore, MDDirector · PromoterGeorge Davis · Pasadena, MDExec · Director · PromoterGeoff Mackay · Brookline, MADirectorXin Huang · Baltimore, MDDirectorGeorge Davis · Baltimore, MDExec · Director · PromoterDavid Oros · Baltimore, MDDirector · PromoterGeoff Mackay · Brookline, MADirectorXin Huang · Baltimore, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗